Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Endo International Plc (ENDP)

2014-04-18@06:15:45 ET
Pharma-Bio 2Q14 Update: $9 Billion in Project Starts Reflects 91% Gain in Industry Capital Investment, an Industrial Info News Alert (INW)

2014-04-17@10:04:39 ET
Noven enters into settlement agreement with Endo and Teikoku (DTM)

2014-04-17@08:01:27 ET
Endo Health Solutions Inc. Announces Receipt of Requisite Tenders and Consents in the Exchange Offers and Consent Solicitations Relating to its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7A 1/4% Senior Notes due 2022 (EUR)

2014-04-17@08:00:00 ET
(PRN)

2014-04-16@21:01:58 ET
Endo International plcCorporate Event Announcement Notice (WSH)

2014-04-16@17:00:26 ET
Noven Announces Settlement of Lidoderm(R) Patent Litigation (BIZ)

2014-04-15@20:59:46 ET
Endo International plcCorporate Event Announcement Notice (WSH)

2014-04-15@18:04:26 ET
Shares of ENDP Down 18.1% Since Downtrend Call on Shares (PSM)

2014-04-15@16:01:16 ET
Endo to Announce First Quarter 2014 Financial Results on May 1, 2014 (EUR)

2014-04-15@16:00:00 ET
Endo to Announce First Quarter 2014 Financial Results on May 1, 2014 (PRN)

2014-04-15@13:25:55 ET
Endo Pharmaceuticals Makes a Move: Down 4.0% (F77)

2014-04-15@09:31:00 ET
Critical Alerts For Royal Dutch Shell, Keurig Green Mountain, Valspar, Lorillard, and Endo Pharmaceuticals Released By InvestorsObserver (PRN)

2014-04-15@08:00:00 ET
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept (PRN)

2014-04-14@10:05:12 ET
Mylan announces favourable settlement agreement with Endo Pharmaceuticals for Frovatriptan Succinate Tablets, 2.5 mg (MTO)

2014-04-14@08:02:11 ET
Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022 (EUR)

2014-04-14@08:00:00 ET
Endo Health Solutions Inc. Amends Exchange Offers and Consent Solicitations for its 7% Senior Notes due 2019, 7.00% Senior Notes due 2020 and 7 1/4% Senior Notes due 2022 (PRN)

2014-04-11@18:17:43 ET
After Yesterday's Decline of 3.52%, Endo Pharmaceuticals Offers Investors Better Value (PSM)

2014-04-11@11:23:11 ET
Endo Pharmaceuticals Shares Sinking Lower, Down 2.8% (F77)